Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma.

Cancer 2011 Aug 11;117(15):3383-92. Epub 2011 Feb 11.

Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Background: Experimental studies suggest that sex hormones may induce or promote the development of hepatocellular carcinoma (HCC). Androgens are converted to estrogens by the CYP19 gene product, aromatase. Hepatic aromatase level and activity have been shown to be markedly elevated in HCC. Aromatase expression in liver tumors is driven by a promoter upstream of CYP19 exon I.6.

Methods: First, the authors identified an A/C polymorphism in the exon I.6 promoter of the CYP19 gene. To determine whether allelic variants in the CYP19 I.6 promoter differ in their ability to drive gene expression, we carried out an in vitro reporter gene assay. Then, the authors studied the association between this polymorphism and HCC risk in 2 complementary case-control studies: 1 in high-risk southern Guangxi, China, and another in low-risk US non-Asians of Los Angeles County.

Results: Transcriptional activity was 60% higher for promoter vectors carrying the rs10459592 C allele compared with those carrying an A allele (P = .007). In both study populations, among subjects negative for at-risk serologic markers of hepatitis B or C, there was a dose-dependent association between number of high activity C allele and risk of HCC (P(trend) = .014). Risk of HCC was significantly higher (odds ratio [OR], 2.25; 95% confidence interval (CI), 1.18-4.31) in subjects homozygous for the C allele compared with those homozygous for the A allele.

Conclusions: This study provides epidemiologic evidence for the role of hepatic aromatization of androgen into estrogen in the development of nonviral hepatitis-related HCC.

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25939
Publisher Site
http://dx.doi.org/10.1002/cncr.25939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138892PMC
August 2011
10 Reads

Publication Analysis

Top Keywords

cyp19 gene
8
hepatocellular carcinoma
8
risk hcc
8
allele compared
8
nonviral hepatitis-related
8
cyp19 promoter
8
hcc
6
gene
5
promoter
5
countyresults transcriptional
4
transcriptional activity
4
allele 007
4
los angeles
4
china low-risk
4
low-risk non-asians
4
non-asians los
4
activity 60%
4
angeles countyresults
4
60% higher
4
allele
4

Altmetric Statistics

References

(Supplied by CrossRef)

Parkin et al.
2002
Epidemiology of hepatocellular carcinoma
Yu et al.
Can J Gastroenterol. 2000
Recent research progress in hepatocellular carcinoma
Kao et al.
J Formos Med Assoc. 2002
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China
Yeh et al.
Cancer Res. 1989
Aflatoxins as risk factors for hepatocellular carcinoma in humans
Wogan et al.
Cancer Res. 1992
Global cancer statistics, 2002
Parkin et al.
CA Cancer J Clin. 2005
Is human hepatocellular carcinoma a hormone-responsive tumor?
Di Maio et al.
World J Gastroenterol. 2008

Similar Publications